/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Andy I. Chen

Oregon Health & Science University(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

79

Papers

3.5K

Citations

22

h-index

32

i10-index

Andy I. Chen is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 22, co-authored 68 publications.

Research Topics

Lymphoma Diagnosis and Treatment CAR-T cell therapy research Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders Acute Lymphoblastic Leukemia research

Papers by this author

works

Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience

2008 · Biology of Blood and Marrow Transplantation · 107 citations

https://doi.org/10.1016/j.bbmt.2008.04.004

Andy I. Chen Alex McMillan Robert S. Negrin Sandra J. Horning

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes

2016 · Biology of Blood and Marrow Transplantation · 22 citations

https://doi.org/10.1016/j.bbmt.2016.03.018

Christopher R. Flowers Luciano J. Costa Marcelo C. Pasquini Jennifer Le‐Rademacher

Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis

2024 · Blood Advances · 20 citations

https://doi.org/10.1182/bloodadvances.2024014164

Peter A. Riedell Connor B. Grady Loretta J. Nastoupil Alejandro Luna

Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse

2016 · Biology of Blood and Marrow Transplantation · 17 citations

https://doi.org/10.1016/j.bbmt.2015.11.315

John Sweetenham Jan Walewski Auayporn Nadamanee Tamás Masszi

The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

2014 · Blood · 17 citations

https://doi.org/10.1182/blood.v124.21.673.673

Craig H. Moskowitz Auayporn Nadamanee Tamás Masszi Edward Agura

Clinical Outcomes of Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow- Up

2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations

https://doi.org/10.1016/s2152-2650(24)00855-3

Stephen J. Schuster Nathan Fowler Michael Dickinson Joaquín Martínez‐López

Research topics

topics

Lymphoma Diagnosis and Treatment

CAR-T cell therapy research

Chronic Lymphocytic Leukemia Research

Viral-associated cancers and disorders

Acute Lymphoblastic Leukemia research

Chat about Author

Papers

Chat

Click to start Chat